MICROREACTOR, METHOD FOR PREPARING SAME, AND METHOD FOR PRODUCING A BIOCHEMICAL OR BIOLOGICAL REACTION

Details for Australian Patent Application No. 2003255578 (hide)

Owner COMMISSARIAT A L'ENERGIE ATOMIQUE

Inventors MARCHAND, Gilles; COMBETTE, Philippe; CONSTANTIN, Olivier; VINET, Francoise

Pub. Number AU-A-2003255578

PCT Number PCT/FR03/01492

PCT Pub. Number WO2003/097229

Priority 02/06084 17.05.02 FR

Filing date 16 May 2003

Wipo publication date 2 December 2003

International Classifications

B01J 019/00 Chemical, physical, or physico-chemical processes in general

G01N 030/60 Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography

B81B 001/00 Devices without movable or flexible elements, e.g. micro-capillary devices

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 02/06084 17.05.02 FR

29 January 2004 Application Open to Public Inspection

  Published as AU-A-2003255578

12 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255579-METHOD OF PERFORMING CRYPTOGRAPHIC FUNCTIONS IN A COMPUTER APPLICATION AND AN APPLICATION ADAPTED TO SAID METHOD

2003255577-NOVEL PEPTIDE COMPOSITIONS AND THE USE THEREOF, IN PARTICULAR, IN THE PREPARATION OF ACTIVE PHARMACEUTICAL COMPOSITIONS AGAINST THE HEPATITIS C VIRUS